Urinary tract infections caused by Pseudomonas aeruginosa: A minireview

Journal of Infection and Public Health

Volumn 2, Issue 3, 2009, Pages 101-111

  Mittal, Rahul ^a,b   Aggarwal, Sudhir ^c   Sharma, Saroj ^b   Chhibber, Sanjay ^b   Harjai, Kusum ^b  

^a CHILDREN S HOSPITAL LOS ANGELES   (United States)

^b PANJAB UNIVERSITY   (India)

^c UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Biofilms; Pseudomonas aeruginosa; Urinary tract infections; Virulence factors

Indexed keywords

BLADDER CATHETERIZATION; HOSPITAL INFECTION; HUMAN; INFECTION SENSITIVITY; PATHOGENESIS; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; REVIEW; URINARY TRACT INFECTION; UROPATHOGENIC ESCHERICHIA COLI;

BIOFILMS; CROSS INFECTION; HUMANS; IMMUNITY, INNATE; IRON; OSMOLAR CONCENTRATION; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; QUORUM SENSING; RISK FACTORS; URINARY CATHETERIZATION; URINARY TRACT; URINARY TRACT INFECTIONS; UROMODULIN; VIRULENCE FACTORS;

EID: 70349730227     PISSN: 18760341     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jiph.2009.08.003     Document Type: Review

References (131)

1. Chang S.L., and Shortliffe L.D. Pediatric urinary tract infections. Pediatr Clin North Am 53 (2006) 379-400
2. Kucheria R., Dasgupta P., Sacks S.H., Khan M.S., and Sheerin N.S. Urinary tract infections: new insights into a common problem. Postgrad Med J 81 (2005) 83-86
3. Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Dis Mon 49 (2003) 53-70
4. Stamm W.E., and Hooton T.M. Management of urinary tract infections in adults. N Engl J Med 329 (1993) 1328-1334
5. Litwin M.S., Saigal C.S., Yano E.M., Avila C., Geschwind S.A., Hanley J.M., et al. Urologic Diseases in America Project: analytical methods and principal findings. J Urol 173 (2005) 933-937
6. Jarvis W.R., and Martone W.J. Predominant pathogens in hospital infections. J Antimicrob Chemother 29 (1992) 19-24
7. Kunin C. Detection, prevention and management of urinary tract infections (1987), Lea and Febiger, Philadelphia
8. Williams D.H., and Schaeffer A.J. Current concepts in urinary tract infections. Minerva Urol Nefrol 56 (2004) 15-31
9. Mittal R., Chhibber S., Sharma S., and Harjai K. Macrophage inflammatory protein-2, neutrophil recruitment and bacterial persistence in an experimental mouse model of urinary tract infection. Microbes Infect 6 (2004) 1326-1332
10. Nicolle L.E. Uncomplicated urinary tract infection in adults including uncomplicated pyelonephritis. Urol Clin North Am 35 (2008) 1-12
11. Bonadio M., Meini M., Gigli C., Longo B., and Vigna A. Urinary tract infection in diabetic patients. Urol Int 63 (1999) 215-219
12. Geerlings S.E., Meiland R., van Lith E.C., Brouwer E.C., Gaastra W., and Hoepelman A.I.M. Adherence of type I-fimbriated Escherichia coli to uroepithelial cells. Diabetes Care 25 (2002) 1405-1409
13. Leone M., Albanese J., Garnier F., Sapin C., Barrau K., Bimar M.C., et al. Risk factors of nosocomial catheter-associated urinary tract infection in a polyvalent intensive care unit. Int Care Med 29 (2003) 929-932
14. Munoz J.A., Perez-Esteban B., Esteban M., de la Escalera S., Gomez M.A., Martinez-Toledo M.V., et al. Growth of moderately halophilic bacteria isolated from sea water using phenol as the sole carbon source. Folia Microbiol (Praha) 46 (2001) 297-302
15. Read R.R., Eberwein P., Dasgupta M.K., Grant S.K., Lam K., Nickel J.C., et al. Peritonitis in peritoneal dialysis: Bacterial colonization by biofilm spread along the catheter. Kid Int 35 (1988) 614-621
16. Warren J.W., Tenney J.H., Hoopes J.M., Muncie H.L., and Anthony W.C. A prospective microbiologic study of bacteriuria in patients with chronic indwelling urethral catheters. J Infect Dis 146 (1982) 719-723
17. Bass III P.F., Jarvis J.A., and Mitchell C.K. Urinary tract infections. Prim Care 30 (2003) 41-61
18. Reid G. Current scientific understanding of urinary tract infections in women: an overview. World J Urol 17 (1999) 336-338
19. Saint S., and Chenoweth C.E. Biofilms and catheter-associated urinary tract infections. Infect Dis Clin North Am 17 (2003) 411-432
20. Shaw G.M., Iovannisci D.M., Yang W., Finnell R.H., Carmichael S.L., Cheng S., et al. Endothelial nitric oxide synthase (NOS3) genetic variants, maternal smoking, vitamin use, and risk of human orofacial clefts. Am J Epidemiol 162 (2005) 1207-1214
21. Kalsi J., Arya M., Wilson P., and Mundy A. Hospital-acquired urinary tract infection. Int J Clin Pract 57 (2003) 388-391
22. Logan K. Indwelling catheters: developing an integrated care pathway package. Nurs Times 99 (2003) 49-51
23. Dickinson G.M., and Bisno A.L. Infections associated with indwelling devices: infections related to extravascular device. Antimicrob Agents Chemother 33 (1989) 602-607
24. Chang S.C., Chen Y.C., and Hsu L.Y. Epidemiologic study of pathogens causing nosocomial infections. J Formos Med Assoc 89 (1990) 1023-1030
25. Fluit A.C., Schmitz F.J., and Verhoef J. Frequency of isolation of pathogens from bloodstream, nosocomial pneumonia, skin and soft tissue, and urinary tract infections occurring in European patients. Eur J Clin Microbiol Infect Dis 20 (2001) 188-191
26. Hootan T.M. Recurrent urinary tract infection in women. Int J Antimicrob Agents 17 (2001) 259-268
27. Johnson J.R., Berggren T., and Manivel J.C. Histopathologic-microbiologic correlates of invasiveness in a mouse model of ascending unobstructed urinary tract infection. J Infect Dis 165 (1992) 299-305
28. Matheson N.R., Potempa J., and Travis J. Interaction of a novel form of Pseudomonas aeruginosa alkaline protease (aeruginolysin) with interleukin-6 and interleukin-8. Biol Chem 387 (2006) 911-915
29. Yates S.P., Jorgensen R., Andersen G.R., and Merrill A.R. Stealth and mimicry by deadly bacterial toxins. Trends Biochem 31 (2006) 123-133
30. Zulianello L., Canard C., Kohler T., Caille D., Lacroix J.S., and Meda P. Rhamnolipids are virulence factors that promote early infiltration of primary human airway epithelia by Pseudomonas aeruginosa. Infect Immun 74 (2006) 3134-3147
31. Veesenmeyer J.L., Hauser A.R., Lisboa T., and Rello J. Pseudomonas aeruginosa virulence and therapy: evolving translational strategies. Crit Care Med 37 (2009) 1777-1786
32. Lysczak J.B., Cannon C.L., and Pier G.B. Establishment of Pseudomonas aeruginosa infection: lessons from a versatile opportunist. Microbes Infect 2 (2000) 1051-1060
33. Smith D.C., Spooner R.A., Watson P.D., Murray J.L., Hodge T.W., Amessou M., et al. Internalized Pseudomonas exotoxin A can exploit multiple pathways to reach the endoplasmic reticulum. Traffic 7 (2006) 379-393
34. Vance R.E., Rietsch A., and Mekalanos J.J. Role of the type III secreted exoenzymes S, T, and Y in systemic spread of Pseudomonas aeruginosa PAO1 in vivo. Infect Immun 73 (2005) 1706-1713
35. Woods D.E., Lam J.S., Parenchych W., Speet D.P., Campbell M., and Godfrey A.J. Correlation of virulence factors from clinical and environmental isolates with pathogenicity in the neutropenic mouse model. Can J Microbiol 43 (1997) 541-551
36. Woods D.E., Schaffer M.S., Rabin H.R., Campbell G.D., and Sokol P.A. Phenotypic comparison of Pseudomonas aeruginosa strains isolated from a variety of clinical sites. J Clin Microbiol 24 (1986) 260-264
37. Hamood A.N., Griswold J.A., and Duhan C.M. Production of extracellular virulence factors by Pseudomonas aeruginosa isolates obtained from tracheal, urinary tract, and wound infections. J Surg Res 61 (1996) 425-432
38. Ciragil P., and Soyletir G. Alginate elastase and alkaline protease production of Pseudomonas aeruginosa strains isolated from various body sites. Mikrobiyol Bull 38 (2004) 341-347
39. Visca P., Chiarini F., Mansi A., Vetriani C., Serino L., and Orsi N. Virulence determinants in Pseudomonas aeruginosa strains from urinary tract infections. Epidemiol Infect 108 (1992) 323-336
40. Mittal R., Khandwaha R.K., Gupta V., Mittal P.K., and Harjai K. Phenotypic characters of urinary isolates of Pseudomonas aeruginosa and their association with mouse renal colonization. Indian J Med Res 123 (2006) 67-72
41. Hoiby N., Johnsen H.K., Moser C., Song Z., Ciofu O., and Kharazmi A. Pseudomonas aeruginosa and the in vitro and in vivo biofilm mode of growth. Micro Infect 3 (2001) 23-35
42. Klausen M., Aaes-Jorgensen A., Molin S., and Tolker-Nielsen T. Involvement of bacterial migration in the development of complex multicellular structures in Pseudomonas aeruginosa biofilms. Mol Microbiol 50 (2003) 61-68
43. Kuchma S.L., Connoly J.P., and O'Toole G.A. A three-component regulatory system regulates biofilm maturation and type III secretion in Pseudomonas aeruginosa. J Bacteriol 187 (2005) 1441-1454
44. Ryder C., Byrd M., and Wozniak D.J. Role of polysaccharides in Pseudomonas aeruginosa biofilm development. Curr Opin Microbiol 10 (2007) 644-648
45. Friedman L., and Kolter R. Two genetic loci produce distinct carbohydrate-rich structural components of the Pseudomonas aerguinosa biofilm matrix. J Bacteriol 186 (2004) 4457-4465
46. Jackson K.D., Starkey M., Kremer S., Parsek M.R., and Wozniak D.J. Identification of psl, a locus encoding a potential exopolysaccharide that is essential for Pseudomonas aeruginosa PAO1 biofilm formation. J Bacteriol 186 (2004) 4466-4475
47. Ma L.Y., Jackson K., Landry R.M., Parsek M.R., and Wozniak D.J. Analysis of Pseudomonas aeruginosa conditional Psl variants reveals roles for the Psl polysaccharide in adhesion and maintaining biofilm structure postattachment. J Bacteriol 188 (2006) 8213-8221
48. Ma L., Lu H., Sprinkle A., Parsek M.R., and Wozniak D.J. Pseudomonas aeruginosa Psl is a galactose- and mannose-rich exopolysaccharide. J Bacteriol 189 (2007) 8353-8356
49. Campisano A., Schroeder C., Schemionek M., Overhage J., and Rehm B.H.A. PslD is a secreted protein required for biofilm formation by Pseudomonas aeruginosa. Appl Environ Microbiol 72 (2006) 3066-3068
50. Overhage J., Schemionek M., Webb J.S., and Rehm B.H.A. Expression of the psl operon in Pseudomonas aeruginosa PAO1 biofilms: PslA performs an essential function in biofilm formation. Appl Environ Microbiol 71 (2005) 4407-4413
51. Vasseur P., Vallet-Gely I., Soscia C., Genin S., and Filloux A. The pel genes of the Pseudomonas aeruginosa PAK strain are involved at early and late stages of biofilm formation. Microbiology 151 (2005) 985-997
52. Boles B.R., Thoendel M., and Singh P.K. Self-generated diversity produces "insurance effects" in biofilm communities. Proc Natl Acad Sci USA 101 (2004) 16630-16635
53. Donlan R.M. Biofilm formation: a clinically relevant microbiological process. Clin Infect Dis 33 (2001) 1387-1392
54. Drenkard E. Antimicrobial resistance of Pseudomonas aeruginosa biofilms. Microbes Infect 5 (2003) 1213-1239
55. Donlan R.M., and Costerton J.W. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 15 (2002) 167-193
56. Hall-Stoodley L., and Stoodley P. Biofilm formation and dispersal and the transmission of human pathogens. Trends Microbiol 13 (2005) 7-10
57. Trautner B.W., and Darouiche R.O. Catheter-associated infections: pathogenesis affects prevention. Arch Intern Med 164 (2004) 842-850
58. Stamm A.M., and Coutinho M.S. Urinary tract infection associated with indwelling bladder catheter incidence and risk factors. Rev Assoc Med Brass 45 (1999) 27-33
59. Trautner B.W., Hull R.A., and Darouiche R.O. Prevention of catheter-associated urinary tract infection. Curr Opin Infect Dis 18 (2005) 37-41
60. Beltran J., Pericas R., Lopez V.L., Virto B.J.L., Prats P.G., and Verger G.G. Urinary infection in patients with short-term bladder catheterization. Med Clin 96 (1991) 161-164
61. Parsons C.L. Pathogenesis of urinary tract infections: bacterial adherence, bladder defense mechanisms. Urol Din North Am 13 (1986) 563-568
62. Bissett L. Reducing the risk of catheter-related urinary tract infection. Nurs Times 101 (2005) 64-65
63. Bonadio M., Pichierri G., Costarelli S., Morelli G., Tanzilli P., Tartaglia T., et al. Catheter-associated urinary tract infections (CAUTI): distribution of uropathogens and patterns of antimicrobial resistance in an Italian hospital (1996-2003). J Chemother 17 (2005) 560-562
64. Niel-Weise B.S., and van den Broek P.J. Antibiotic policies for short-term catheter bladder drainage in adults. Cochrane Database Syst Rev 3 (2005) CD005428
65. Locci R., Peters G., and Pulverer G. Microbiol colonization of prosthetic devices. I. Scanning electron microscopy of naturally infected intravenous catheters. Zentralbl Bakteriol Microbiol Hyg Abt Orig 173 (1981) 285-289
66. Peters G., Locci R., and Pulverer G. Microbial colonization of prosthetic devices. II. Scanning electron microscopy of naturally infected intravenous catheters. Zentralbl Bakteriol Microbiol Hyg Abt Orig 173 (1982) 293-296
67. Costerton J.W., Irvin R.T., and Cheng K.J. The bacterial glycocalyx in nature and disease. Ann Rev Microbiol 35 (1981) 299-324
68. Nickel J.C., Grant S.K., and Costerton J.W. Catheter-associated bacteriuria. An experimental study. Urology 26 (1985) 369-375
69. Ganderton L., Chawla J., Winters C., Wimpenny J., and Stickler D. Scanning electron microscopy of bacterial biofilms on indwelling bladder catheters. Eur J Clin Microbiol Infect Dis 11 (1992) 789-796
70. Stickler D.J., Morris N.S., McLean R.J., and Fuqua C. Biofilms on indwelling uretheral catheters produce quorum sensing signal molecules in situ and in vitro. Appl Environ Microbiol 64 (1998) 3486-3490
71. Kurosaka Y., Ishida Y., Yamamura E., Takase H., Otani T., and Kumon H. A non-surgical rat model of foreign body-associated urinary tract infection with Pseudomonas aeruginosa. Microbiol Immunol 45 (2001) 9-15
72. Webb J.S., Lau M., and Kjelleberg S. Bacteriophage and phenotypic variation in Pseudomonas aeruginosa biofilm development. J Bacteriol 186 (2004) 8066-8073
73. Rice S.A., Tan C.H., Mikkelsen P.J., Kung V., Woo J., Tay M., et al. The biofilm life cycle and virulence of Pseudomonas aeruginosa are dependent on a filamentous prophage. ISME J 3 (2009) 271-282
74. Mittal R., Sharma S., Chhibber S., and Harjai K. Contribution of free radicals to Pseudomonas aeruginosa induced acute pyelonephritis. Microb Pathog 45 (2008) 323-330
75. Gambello M.J., and Iglewski B.H. Cloning and characterization of the Pseudomonas aeruginosa lasR gene, a transcriptional activator of elastase expression. J Bacteriol 173 (1991) 3000-3009
76. Ochsner U.A., and Reiser J. Autoinducer-mediated regulation of rhamnolipid biosurfactant synthesis in Pseudomonas aeruginosa. Proc Natl Acad Sci USA 92 (1995) 6424-6428
77. Pearson J.P., Gray K.M., Passador L., Tucker K.D., Eberhard A., Iglewski B.H., et al. Structure of the autoinducer required for expression of Pseudomonas aeruginosa virulence genes. Proc Natl Acad Sci USA 91 (1994) 197-201
78. Pearson J.P., Passador L., Iglewski B.H., and Greenberg E.P. A second N-acylhomoserine lactone signal produced by Pseudomonas aeruginosa. Proc Natl Acad Sci USA 92 (1995) 1490-1494
79. Winson M.K., Camara M., Latifi A., Foglino M., Chhabra S.R., Daykin M., et al. Multiple N-acyl-l-homoserine lactone signal molecules regulate production of virulence determinants and secondary metabolites in Pseudomonas aeruginosa. Proc Natl Acad Sci USA 92 (1995) 9427-9431
80. Seed P.C., Passador L., and Iglewski B.H. Activation of the Pseudomonas aeruginosa lasI gene by LasR and the Pseudomonas autoinducer PAI: an autoinduction regulatory hierarchy. J Bacteriol 177 (1995) 654-659
81. Passador L., Cook J.M., Gambello M.J., Rust L., and Iglewski B.H. Expression of Pseudomonas aeruginosa virulence genes requires cell-to-cell communication. Science 260 (1993) 1127-1130
82. Pearson J.P., Pesci E.C., and Iglewski B.H. Roles of Pseudomonas aeruginosa las and rhl quorum-sensing systems in control of elastase and rhamnolipid biosynthesis genes. J Bacteriol 179 (1997) 5756-5767
83. Gambello M.J., Kaye S., and Iglewski B.H. LasR of Pseudomonas aeruginosa is a transcriptional activator of the alkaline protease gene (apr) and an enhancer of exotoxin A expression. Infect Immun 61 (1993) 1180-1184
84. Chapon-Herve V., Akrim M., Latifi A., Williams P., Lazdunski A., and Bally M. Regulation of the xcp secretion pathway by multiple quorum sensing modulons in Pseudomonas aeruginosa. Mol Microbiol 24 (1997) 1169-1178
85. Latifi A., Foglino M., Tanaka K., Williams P., and Lazdunski A. A hierarchical quorum-sensing cascade in Pseudomonas aeruginosa links the transcriptional activators LasR and RhIR (VsmR) to expression of the stationary-phase sigma factor RpoS. Mol Microbiol 21 (1996) 1137-1146
86. Pesci E.C., Pearson J.P., Seed P.C., and Iglewski B.H. Regulation of las and rhl quorum sensing in Pseudomonas aeruginosa. J Bacteriol 179 (1997) 3127-3132
87. Brint J.M., and Ohman D.E. Synthesis of multiple exoproducts in Pseudomonas aeruginosa is under the control of RhlR-RhlI, another set of regulators in strain PAO1 with homology to the autoinducer-responsive LuxR-LuxI family. J Bacteriol 177 (1995) 7155-7163
88. Davies D.G., Parsek M.R., Pearson J.P., Iglewski B.H., Costerton J.W., and Greenberg E.P. The involvement of cell-to-cell signals in the development of a bacterial biofilm. Science 280 (1998) 295-298
89. Lesprit P., Faurisson F., Join-Lambert O., Roudot-Thoraval F., Foglino M., Vissuzaine C., et al. Role of the quorum-sensing system in experimental pneumonia due to Pseudomonas aeruginosa in rats. Am J Respir Crit Care Med 167 (2003) 1478-1482
90. Pearson J.P., Feldman M., Iglewski B.H., and Prince A. Pseudomonas aeruginosa cell-to-cell signaling is required for virulence in a model of acute pulmonary infection. Infect Immun 68 (2000) 4331-4334
91. Rumbaugh K.P., Griswold J.A., and Hamood A.N. Pseudomonas aeruginosa strains obtained from patients with tracheal, urinary tract and wound infection: variations in virulence factors and virulence genes. J Hosp Infect 43 (1999) 211-218
92. Wu H., Song Z., Givskov M., Doring G., Worlitzsch D., Mathee K., et al. Pseudomonas aeruginosa mutations in lasI and rhlI quorum sensing systems result in milder chronic lung infection. Microbiology 147 (2001) 1105-1113
93. Zhu H., Bandara R., Conibear T.C., Thuruthyil S.J., Rice S.A., Kjelleberg S., et al. Pseudomonas aeruginosa with lasI quorum-sensing deficiency during corneal infection. Invest Ophthalmol Vis Sci 45 (2004) 1897-1903
94. Parker C.T., and Sperandio V. Cell-to-cell signalling during pathogenesis. Cell Microbiol 11 (2009) 363-369
95. Mittal R., Sharma S., Chhibber S., and Harjai K. Contribution of quorum-sensing systems to virulence of Pseudomonas aeruginosa in an experimental pyelonephritis model. J Microbiol Immunol Infect 39 (2006) 302-309
96. Haussler S., and Becker T. The Pseudomonas quinolone signal (PQS) balances life and death in Pseudomonas aeruginosa populations. PLoS Pathog 4 (2008) e1000166
97. Farrow III J.M., Sund Z.M., Ellison M.L., Wade D.S., Coleman J.P., and Pesci E.C. PqsE functions independently of PqsR-Pseudomonas quinolone signal and enhances the rhl quorum-sensing system. J Bacteriol 190 (2008) 7043-7051
98. Dubern J.F., and Diggle S.P. Quorum sensing by 2-alkyl-4-quinolones in Pseudomonas aeruginosa and other bacterial species. Mol Biosyst 4 (2008) 882-888
99. Kim E.J., Sabra W., and Zeng A.P. Iron deficiency leads to inhibition of oxygen transfer and enhanced formation of virulence factors in cultures of Pseudomonas aeruginosa PAO1. Microbiology 149 (2003) 2627-2634
100. Shand G.H., Anwar H., Kadurugamuwa J., Brown M., Silvermann S.H., and Melling J. In vivo evidence that bacteria in urinary tract infection grow under iron restricted conditions. Infect Immun 48 (1985) 35-39
101. Suh S.J., Suh S.L., Woods D.E., Hassett D.J., West S.E.H., and Ohman D.E. Effect of rpoS mutation on the stress response and expression of virulence factors in Pseudomonas aeruginosa. J Bacteriol 181 (1999) 3890-3897
102. Lamont I.L., Beare P.A., Ochsner U., Vasil A.I., and Vasil M.L. Siderophore mediated signaling regulates virulence factor production in Pseudomonas aeruginosa. Proc Natl Acad Sci USA 99 (2002) 7072-7077
103. Sriyosachati S., and Cox C.D. Siderophore mediated iron acquisition from transferrin by Pseudomonas aeruginosa. Infect Immun 52 (1986) 885-891
104. Winzer K., Falconer C., Garber N.C., Diggle S.P., Camara M., and Williams P. The Pseudomonas aeruginosa lectins PA-IL and PA-IIL are controlled by quorum sensing and by RpoS. J Bacteriol 182 (2000) 6401-6411
105. Bullen J.J., Rogers H.J., Spalding P.B., and Ward C.G. Iron and infection: the heart of the matter. FEMS Immunol Med Microbiol 43 (2005) 325-330
106. Bjorn M.J., Iglewski B.H., Ives S.K., Sadoff J.C., and Vasil M.L. Effect of iron on yields of exotoxin A in cultures of Pseudomonas aeruginosa PA-103. Infect Immun 19 (1978) 785-791
107. Bjorn M.J., Sokol P.A., and Iglewski B.H. Influence of iron on yields of extracellular products in Pseudomonas aeruginosa cultures. J Bacteriol 138 (1979) 193-200
108. Woods D.E., Iglewski B.H., and Johanson W.G. Host and bacterial factors in the colonization of the respiratory tract. In: Schlessinger D. (Ed). Microbiology (1982), American Society for Microbiology, Washington, D.C. 348-352
109. Sokol P.A., and Woods D.E. Relationship of iron and extracellular virulence factors to Pseudomonas aeruginosa lung infections. J Med Microbiol 18 (1984) 125-133
110. Mittal R., Sharma S., Chhibber S., and Harjai K. Iron dictates the virulence of Pseudomonas aeruginosa in urinary tract infections. J Biomed Sci 15 (2008) 731-741
111. Mittal R., Sharma S., Chhibber S., and Harjai K. Effect of osmolarity on virulence of uropathogenic Pseudomonas aeruginosa. Am J Biomed Sci 1 (2009) 12-26
112. Culham D.E., Dalgado C., Gyles C.L., Mamelak D., MacLellan S., and Wood J.W. Osmoregulatory transporter ProP influences colonization of the urinary tract by Escherichia coli. Microbiology 144 (1998) 91-102
113. Kokot F., and Dulawa J. Tamm-Horsfall protein updated. Nephron 85 (2000) 97-102
114. Seraffini-cesssi F., Malagolini N., and Cavallone D. Tamm-Horsfall glycoprotein: biology and clinical relevance. Am J Kidney Dis 42 (2003) 658-676
115. Duncan J.L. Differential effect of Tamm-Horsfall protein on adherence of Escherichia coli to transitional epithelial cells. J Infec Dis 158 (1988) 1379-1389
116. Mittal R., Sharma S., Chhibber S., and Harjai K. Alteration in virulence characteristics of biofilm cells of Pseudomonas aeruginosa in presence of Tamm-Horsfall Protein. World J Microbiol Biotechnol 22 (2006) 915-919
117. Harjai K., Mittal R., Chhibber S., and Sharma S. Contribution of Tamm-Horsfall protein to virulence of Pseudomonas aeruginosa in urinary tract infection. Microbes Infect 7 (2005) 132-137
118. Hawthorn L.A., Bruce A.W., and Reid G. Ability of uropathogens to bind to Tamm-Horsfall protein coated renal tubular cells. Urol Res 1 (1991) 301-304
119. Nathan C.F. Secretory products of macrophages. J Clin Invest 79 (1987) 319-326
120. Mittal R., Sharma S., Chhibber S., and Harjai K. Effect of macrophage secretory products on elaboration of virulence factors by planktonic and biofilm cells of Pseudomonas aeruginosa. Comp Immunol Microbiol Infect Dis 29 (2006) 12-26
121. Haraoka M., Hang L., Frendeus B., Godaly G., Burdick M., Strieter R., et al. Neutrophil recruitment and resistance to urinary tract infection. J Infect Dis 180 (1999) 1220-1229
122. Jung H., Eckmann L., Yang S., Panja A., Fierer J., Wroblewska E., et al. A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion. J Clin Invest 95 (1995) 55-65
123. Godaly G., Bergsten G., Hang L., Fischer H., Frendeus B., Lundstedt A.C., et al. Neutrophil recruitment, chemokine receptors, and resistance to mucosal infection. J Leukoc Biol 69 (2001) 899-906
124. Svanborg C., Bergsten G., Fischer H., Godaly G., Gustafsson M., Karpman D., et al. Uropathogenic Escherichia coli as a model of host-parasite interaction. Curr Opin Microbiol 9 (2006) 33-39
125. Agace W.W., Hedges S.R., Ceska M., and Svanborg C. Interleukin-8 and the neutrophil response to mucosal gram-negative infection. J Clin Invest 92 (1993) 780-785
126. Hedges S., Linder H., de Man P., and Svanborg Eden C. Ciclosporin-dependent, nu-independent, mucosal interleukin 6 response to gram-negative bacteria. Scand J Immunol 31 (1990) 335-343
127. Jirik F.R., Podor T.J., Hirano T., Kishimoto T., Loskutoff D.J., Carson D.A., et al. Bacterial lipopolysaccharide and inflammatory mediators augment IL-6 secretion by human endothelial cells. J Immunol 142 (1989) 144-147
128. Lopponow H., Libby P., Freudenberg M., Krauss J., Weckesser J., and Mayer H. Cytokine induction by lipopolysaccharide (LPS) corresponds to lethal toxicity and is inhibited by nontoxic Rhodobacter capsulatus LPS. Infect Immun 58 (1990) 3743-3750
129. Godaly G., Bergsten G., Frendeus B., Hang L., Hedlund M., Karpman D., et al. Innate defences and resistance to gram negative mucosal infection. Adv Exp Med Biol 485 (2000) 9-24
130. Olszyna D.P., Vermeulen H., Baan A.H., Speelman P., van Deventer S.J., Gouma D.J., et al. Urine interleukin-8 is a marker for urinary tract infection in postoperative patients. Infection 29 (2001) 274-277
131. Kassir K., Vargas-Shiraishi O., Zaldivar F., Berman M., Singh J., and Arrieta A. Cytokine profiles of pediatric patients treated with antibiotics for pyelonephritis: potential therapeutic impact. Clin Diagn Lab Immunol 8 (2001) 1060-1063